February 10th, 2020
•Blood-based biomarkers for neurodegenerative diseases are essential for implementing large-scale clinical studies. A reliable and validated blood test should require a small sample volume as well as be a less invasive sampling method, affordable, and reproducible. This paper demonstrates that high-throughput capillary electrophoresis immunoassay satisfies criteria for potential biomarker development.
Tags
Related Videos
How to Create and Use Binocular Rivalry
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders
Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake
Exploring Deep Space - Uncovering the Anatomy of Periventricular Structures to Reveal the Lateral Ventricles of the Human Brain
In Vivo Calcium Imaging of Lateral-line Hair Cells in Larval Zebrafish
Use of In Vivo Single-fiber Recording and Intact Dorsal Root Ganglion with Attached Sciatic Nerve to Examine the Mechanism of Conduction Failure
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Activity of Posterior Lateral Line Afferent Neurons during Swimming in Zebrafish
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved